Diagnostic accuracy of the BACs‐on‐Beads™ assay versus karyotyping for prenatal detection of chromosomal abnormalities: a retrospective consecutive case series
- 3 June 2014
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 121 (10), 1245-1252
- https://doi.org/10.1111/1471-0528.12873
Abstract
To evaluate the diagnostic performance of the BACs-on-Beads(™) (BoBs(™)) assay for prenatal detection of chromosomal abnormalities. Retrospective study. Tertiary prenatal diagnosis centre. Women referred for prenatal diagnosis. We retrieved 2153 archived DNA samples collected between January 2010 and August 2011 for the BoBs(™) assay. These samples had previously been tested by quantitative fluorescence polymerase chain reaction (QF-PCR) and karyotyping. In the BoBs(™) assay a sample was defined as normal disomic when the ratio of the fluorescence intensities in a chromosome locus lay within the threshold (mean ratio ± 2SD), and as deleted or duplicated when the ratio was below the lower threshold (0.6-0.8) or above the upper threshold (1.3-1.4), respectively. The BoBs(™) results were further validated by microarray and compared in a blinded manner with the original QF-PCR and karyotyping results. Concordance of any numerical, structural, and submicroscopic chromosomal abnormalities between the methods. BACs-on-Beads(™) was similar to karyotyping and QF-PCR in detecting trisomy 13, trisomy 18, trisomy 21, and sex chromosomal aneuploidies, and superior to QF-PCR in detecting major structural abnormalities (53.3 versus 13.3%) and mosaicism (28.6 versus 0%) involving chromosomal abnormalities other than the common aneuploidies. BoBs(™) detected six microdeletion syndromes missed by karyotyping and QF-PCR; however, BoBs(™) missed two cases of triploidy identified by QF-PCR. Therefore, the sensitivity of BoBs(™) is 96.7% (95% CI 92.6-98.7%), and its specificity is 100% (95% CI 99.8-100%). BACs-on-Beads(™) can replace QF-PCR for triaging in prenatal diagnosis, and gives a better diagnostic yield than current rapid aneuploidy tests.Keywords
Funding Information
- Hong Kong Health and Medical Research Fund, Hong Kong (08090401)
- National Basic Research Program of China (2012CB944600)
This publication has 31 references indexed in Scilit:
- Classification of pathogenic or benign status of CNVs detected by microarray analysis.Expert Review of Molecular Diagnostics, 2010
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesAmerican Journal of Human Genetics, 2010
- The impact of human copy number variation on a new era of genetic testingBJOG: An International Journal of Obstetrics and Gynaecology, 2010
- Comparison of Multiplex Ligation-Dependent Probe Amplification and Karyotyping in Prenatal DiagnosisObstetrics & Gynecology, 2010
- Multiplex ligation‐dependent probe amplification (MLPA) in prenatal diagnosis—experience of a large series of rapid testing for aneuploidy of chromosomes 13, 18, 21, X, and YPrenatal Diagnosis, 2008
- Comparison of microarray‐based detection rates for cytogenetic abnormalities in prenatal and neonatal specimensPrenatal Diagnosis, 2008
- What’s new in karyotyping? The move towards array comparative genomic hybridisation (CGH)European Journal of Pediatrics, 2007
- Molecular cytogenetic and rapid aneuploidy detection methods in prenatal diagnosisAmerican Journal Of Medical Genetics Part C-Seminars In Medical Genetics, 2007
- Clinical application of multiplex quantitative fluorescent polymerase chain reaction (QF-PCR) for the rapid prenatal detection of common chromosome aneuploidiesMolecular Human Reproduction, 2001
- Development and implementation of a new rapid aneuploidy diagnostic service within the UK National Health Service and implications for the future of prenatal diagnosisThe Lancet, 2001